A practical comparison of a retail retinal bottle and an assessment-led prescription service, without treating unlike percentages as a ranking.
Begin with the change you want to see
“Anti-aging” can mean a change in fine lines, surface texture, uneven color or simply how comfortable skin feels. Those are different goals. Before comparing a retail retinal serum with a prescription subscription, write down the main concern and what has already been tried. That makes a product discussion more useful than asking for the strongest available ingredient.
A retail serum is purchased as a fixed formulation. A personalized prescription begins with an assessment and may be adjusted. The second route adds a clinical decision, but the word personalized does not guarantee a better result. The actual formula and the quality of follow-up matter. Dermatica’s public treatment description, for example, offers possible actives and ongoing check-ins rather than one identical anti-aging bottle.[source]
Put the molecule beside the percentage
Medik8’s Crystal Retinal range uses retinaldehyde at concentrations from 0.01% to 0.24%. Dermatica lists tretinoin among its prescription options. These are not interchangeable molecules, so putting the percentages into one ascending table would create a false potency ranking. Keep the product category, exact ingredient and concentration together.[source][source]
A stronger version within one range also does not guarantee a better personal outcome. An uncomfortable formula may be difficult to use consistently. AAD guidance emphasizes choosing retinoid products with skin type and tolerance in mind. Persistent burning, marked irritation or other concerns deserve advice rather than an automatic move to a higher strength.[source]
Ask which finished product was studied
A scientific paper about an ingredient is useful background. A study of the purchased formula answers a narrower, more direct question. A trial comparing that formula with another treatment would answer a different question again. Confusion starts when a brand moves between those levels without keeping the limitations visible.
For Crystal Retinal, the manufacturer identifies a 33-person, 12-week study of the 6 variant. That is not direct evidence for every strength and not a trial against Dermatica, Agency or CoreAge Rx. For a personalized prescription, the ingredients may have substantial clinical history while the exact patient-specific combination has not been studied as a finished product. FDA notes that compounded medicines are not FDA-approved.[source][source]
Compare the same span of time
A bottle price is easy to see but says little about how long a routine will last. A subscription’s monthly equivalent can obscure a larger shipment charge. Record the quantity, expected refill timing, consultation charge, shipping and any products that renew automatically. Use the same comparison period for both options and leave uncertain costs marked as uncertain.
For example, Dermatica describes an approximately 56-day delivery cycle alongside a $29.95 monthly figure and an introductory offer. That is a reason to inspect checkout, not to assume the first payment repeats. For a retail serum, select the exact variant before writing down a price. Repeatedly replacing unsuitable purchases can outweigh a difference in the first bottle.[source]
Bring a routine inventory to the decision
Include current prescriptions, exfoliants and previous reactions in the discussion. Two products marketed for separate concerns can still overlap in ways that make a routine uncomfortable. Pregnancy and plans for pregnancy require particular attention: the AAD advises avoiding retinoids during pregnancy. This guide is not a way to choose a prescription strength or bypass an assessment.[source]
A good next step is a short list of unanswered questions: What exactly is in the formula? Which outcome is realistic? When will it be reviewed? Who helps if there is a problem? Compare our Crystal Retinal, Dermatica formula and Smooth Move reviews with those questions beside you.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Dermatica: personalized anti-aging treatmentOfficial source; commercial claims are attributed to the provider. · Checked October 10, 2026
- Medik8: Crystal Retinal ingredients, strengths and study notesManufacturer information; the cited 33-person study concerns Crystal Retinal 6, not every strength. · Checked October 10, 2026
- American Academy of Dermatology — Retinoid or retinol?Dermatology guidance on retinoids, irritation and pregnancy · Checked October 10, 2026
- American Academy of Dermatology: skin care during pregnancySpecialty-society patient guidance. · Checked October 10, 2026
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations · Checked October 10, 2026